作者: M. Sorri , K. Jokinen , A. Palva
DOI: 10.3109/00016487809123463
关键词:
摘要: DSCG was tested on 38 patients with perennial rhinitis in the form of a nasal spray (2%) double-blind cross-over trial. Few investigated parameters whole material showed any significant preference DSCG. A marked drug order effect shown; group receiving placebo first, most clinical assessed both by clinician and patient were better for therapeutical trial is worth trying rhinitis.